Mamedica

London, United Kingdom
Medical cannabis treatments are provided by Mamedica for chronic conditions.

About Mamedica

Mamedica is a company based in London (United Kingdom). It operates as a HealthTech, and Subscription Services. Mamedica has raised $5.97 million across 1 funding round from investors including Casa Verde, Mark Noble and Jay Rutland. Mamedica offers products and services including Flower, Oils, Vapes, Pastilles, and Capsules.

  • Headquarter London, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.97 M (USD)

    in 1 rounds

  • Latest Funding Round
    $5.97 M (USD), Seed

    Sep 16, 2025

  • Investors
    Casa Verde

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Mamedica

Mamedica offers a comprehensive portfolio of products and services, including Flower, Oils, Vapes, Pastilles, and Capsules. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Dried cannabis flower is provided for vaporisation relief.

Cannabis oil extracts are offered for precise dosing.

Discreet vapour delivery is provided using quality extracts.

Flavoured edibles are designed for controlled daily relief.

Odourless capsules are made for controlled daily relief.

Funding Insights of Mamedica

Mamedica has successfully raised a total of $5.97M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.97 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $6.0M
  • First Round

    (16 Sep 2025)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2025 Amount Seed - Mamedica Valuation Casa Verde Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mamedica

Mamedica has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Casa Verde, Mark Noble and Jay Rutland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Investment in cannabis industry startups is facilitated by Casa Verde.
Founded Year Domain Location

Mark Noble

-
Founded Year Domain Location

Jay Rutland

-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mamedica

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Mamedica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mamedica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mamedica

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mamedica

Frequently Asked Questions about Mamedica

Where is Mamedica located?

Mamedica is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Is Mamedica a funded company?

Mamedica is a funded company, having raised a total of $5.97M across 1 funding round to date. The company's 1st funding round was a Seed of $5.97M, raised on Sep 16, 2025.

What does Mamedica do?

Medical cannabis solutions are offered by Mamedica for patients with chronic conditions such as anxiety, chronic pain, and insomnia. A range of products including flower, oils, vapes, pastilles, and capsules are provided to ensure tailored treatment plans. The healthcare sector is primarily served, focusing on conditions unresponsive to conventional treatments. Consultations with specialist doctors are conducted to assess eligibility and create personalized plans. Delivery services are arranged directly to patients across the UK.

What products or services does Mamedica offer?

Mamedica offers Flower, Oils, Vapes, Pastilles, and Capsules.

Who are Mamedica's investors?

Mamedica has 3 investors. Key investors include Casa Verde, Mark Noble, and Jay Rutland.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available